指南針(300803.SZ):一季度主要開展了全贏系列私享家版軟件產品營銷
格隆匯6月27日丨指南針(300803.SZ)近期在接待機構調研時表示,公司基於今年工作整體優化調度考慮,一季度主要開展了全贏系列私享家版軟件產品營銷,並未同期營銷上年同期的全贏決策智能阿爾法版產品,該產品擬安排在今年下半年擇期啟動。此外,公司安排高端產品的推廣時機,除固有的年度安排外,也會綜合考慮市場整體情況、客户規模和需求的積累、產品迭代研發的準備情況,以及經營團隊的工作安排等因素。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.